Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses.

Autor: Ridgway, Harry1,2 (AUTHOR) ridgway@vtc.net, Apostolopoulos, Vasso3,4 (AUTHOR) anthony.zulli@vu.edu.au, Moore, Graham J.5,6 (AUTHOR) mooregj@shaw.ca, Gadanec, Laura Kate4 (AUTHOR) jordan.swiderski@live.vu.edu.au, Zulli, Anthony4 (AUTHOR), Swiderski, Jordan4 (AUTHOR), Tsiodras, Sotirios7 (AUTHOR) sotirios.tsiodras@gmail.com, Kelaidonis, Konstantinos8 (AUTHOR) k.kelaidonis@gmail.com, Chasapis, Christos T.9 (AUTHOR) cchasapis@eie.gr, Matsoukas, John M.4,6,8,10 (AUTHOR) laura.gadanec@live.vu.edu.au
Zdroj: Viruses (1999-4915). Nov2024, Vol. 16 Issue 11, p1776. 26p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje